Logo image of DRIO

DARIOHEALTH CORP (DRIO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:DRIO - US23725P3082 - Common Stock

12.13 USD
-1.35 (-10.01%)
Last: 1/7/2026, 8:00:01 PM
12.37 USD
+0.24 (+1.98%)
After Hours: 1/7/2026, 8:00:01 PM
Fundamental Rating

3

Taking everything into account, DRIO scores 3 out of 10 in our fundamental rating. DRIO was compared to 35 industry peers in the Health Care Technology industry. While DRIO seems to be doing ok healthwise, there are quite some concerns on its profitability. DRIO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DRIO had negative earnings in the past year.
In the past year DRIO has reported a negative cash flow from operations.
DRIO had negative earnings in each of the past 5 years.
DRIO had a negative operating cash flow in each of the past 5 years.
DRIO Yearly Net Income VS EBIT VS OCF VS FCFDRIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

The Return On Assets of DRIO (-31.52%) is worse than 60.00% of its industry peers.
DRIO's Return On Equity of -49.53% is in line compared to the rest of the industry. DRIO outperforms 51.43% of its industry peers.
Industry RankSector Rank
ROA -31.52%
ROE -49.53%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
DRIO Yearly ROA, ROE, ROICDRIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

DRIO has a Gross Margin of 56.86%. This is comparable to the rest of the industry: DRIO outperforms 45.71% of its industry peers.
In the last couple of years the Gross Margin of DRIO has grown nicely.
DRIO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
DRIO Yearly Profit, Operating, Gross MarginsDRIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

4

2. Health

2.1 Basic Checks

DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DRIO has more shares outstanding
DRIO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DRIO has been reduced compared to a year ago.
DRIO Yearly Shares OutstandingDRIO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
DRIO Yearly Total Debt VS Total AssetsDRIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

DRIO has an Altman-Z score of -4.54. This is a bad value and indicates that DRIO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DRIO (-4.54) is worse than 74.29% of its industry peers.
A Debt/Equity ratio of 0.41 indicates that DRIO is not too dependend on debt financing.
DRIO has a worse Debt to Equity ratio (0.41) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z -4.54
ROIC/WACCN/A
WACC11.1%
DRIO Yearly LT Debt VS Equity VS FCFDRIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

A Current Ratio of 4.55 indicates that DRIO has no problem at all paying its short term obligations.
DRIO's Current ratio of 4.55 is amongst the best of the industry. DRIO outperforms 82.86% of its industry peers.
A Quick Ratio of 4.02 indicates that DRIO has no problem at all paying its short term obligations.
The Quick ratio of DRIO (4.02) is better than 82.86% of its industry peers.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 4.02
DRIO Yearly Current Assets VS Current LiabilitesDRIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 74.56% over the past year.
Looking at the last year, DRIO shows a small growth in Revenue. The Revenue has grown by 7.29% in the last year.
The Revenue has been growing by 29.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)74.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%159.2%
Revenue 1Y (TTM)7.29%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-32.55%

3.2 Future

Based on estimates for the next years, DRIO will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.89% on average per year.
DRIO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.37% yearly.
EPS Next Y-118.81%
EPS Next 2Y26.45%
EPS Next 3Y6.29%
EPS Next 5Y15.89%
Revenue Next Year-10.78%
Revenue Next 2Y3.48%
Revenue Next 3Y5.47%
Revenue Next 5Y9.37%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DRIO Yearly Revenue VS EstimatesDRIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
DRIO Yearly EPS VS EstimatesDRIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -200 -400 -600 -800

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DRIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DRIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRIO Price Earnings VS Forward Price EarningsDRIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRIO Per share dataDRIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.45%
EPS Next 3Y6.29%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DRIO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

DARIOHEALTH CORP

NASDAQ:DRIO (1/7/2026, 8:00:01 PM)

After market: 12.37 +0.24 (+1.98%)

12.13

-1.35 (-10.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-13 2025-11-13/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners11.75%
Inst Owner Change0%
Ins Owners12.01%
Ins Owner Change5.22%
Market Cap82.12M
Revenue(TTM)24.73M
Net Income(TTM)-37.11M
Analysts82
Price Target18.61 (53.42%)
Short Float %1.09%
Short Ratio1.97
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.8%
Min EPS beat(2)24.37%
Max EPS beat(2)159.22%
EPS beat(4)3
Avg EPS beat(4)59.87%
Min EPS beat(4)-17.64%
Max EPS beat(4)159.22%
EPS beat(8)7
Avg EPS beat(8)49.83%
EPS beat(12)9
Avg EPS beat(12)35%
EPS beat(16)11
Avg EPS beat(16)28.68%
Revenue beat(2)0
Avg Revenue beat(2)-18.56%
Min Revenue beat(2)-23.78%
Max Revenue beat(2)-13.34%
Revenue beat(4)1
Avg Revenue beat(4)-11.91%
Min Revenue beat(4)-23.78%
Max Revenue beat(4)0.92%
Revenue beat(8)1
Avg Revenue beat(8)-11.12%
Revenue beat(12)3
Avg Revenue beat(12)-10.13%
Revenue beat(16)5
Avg Revenue beat(16)-8.21%
PT rev (1m)-8.75%
PT rev (3m)-17.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-29.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.32
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 74.52
EV/EBITDA N/A
EPS(TTM)-5.24
EYN/A
EPS(NY)-4.97
Fwd EYN/A
FCF(TTM)-3.98
FCFYN/A
OCF(TTM)-3.96
OCFYN/A
SpS3.65
BVpS11.07
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.52%
ROE -49.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.86%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.89%
Cap/Sales 0.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 4.02
Altman-Z -4.54
F-Score5
WACC11.1%
ROIC/WACCN/A
Cap/Depr(3y)8.55%
Cap/Depr(5y)19.33%
Cap/Sales(3y)1.81%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%159.2%
EPS Next Y-118.81%
EPS Next 2Y26.45%
EPS Next 3Y6.29%
EPS Next 5Y15.89%
Revenue 1Y (TTM)7.29%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-32.55%
Revenue Next Year-10.78%
Revenue Next 2Y3.48%
Revenue Next 3Y5.47%
Revenue Next 5Y9.37%
EBIT growth 1Y33.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.79%
EBIT Next 3Y25.02%
EBIT Next 5Y16.13%
FCF growth 1Y14.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.57%
OCF growth 3YN/A
OCF growth 5YN/A

DARIOHEALTH CORP / DRIO FAQ

What is the fundamental rating for DRIO stock?

ChartMill assigns a fundamental rating of 3 / 10 to DRIO.


Can you provide the valuation status for DARIOHEALTH CORP?

ChartMill assigns a valuation rating of 0 / 10 to DARIOHEALTH CORP (DRIO). This can be considered as Overvalued.


Can you provide the profitability details for DARIOHEALTH CORP?

DARIOHEALTH CORP (DRIO) has a profitability rating of 1 / 10.


How financially healthy is DARIOHEALTH CORP?

The financial health rating of DARIOHEALTH CORP (DRIO) is 4 / 10.